REVEAL THE OPTIONS - Know Now BRAF...KNOW NOW BRAF TESTING PROGRAM KnowNowBRAF.com Novartis is now...
7
REVEAL THE OPTIONS Understanding your patient’s BRAF status today may help you make a treatment decision for tomorrow KnowNowBRAF.com Novartis is here to shine a light on your patient's BRAF mutation status. INTRODUCTION FAQs/CONTACT US HOW TO USE THE PROGRAM
Transcript of REVEAL THE OPTIONS - Know Now BRAF...KNOW NOW BRAF TESTING PROGRAM KnowNowBRAF.com Novartis is now...
REVEAL THE OPTIONSUnderstanding your patient’s BRAF status today may help you make a treatment decision for tomorrow
KnowNowBRAF.com
Novartis is here to shine a light on your patient's BRAF mutation status.
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAM
KNOW NOW BRAF TESTING PROGRAMKnowNowBRAF.com
Novartis is now offering BRAF testing for all of your patients with stage III or stage IV melanoma.*The Know Now BRAF Testing Program will use the THxID®-BRAF kit to test for V600E/K mutations, and the results you need will be available approximately 48 hours after the Quest lab receives the BRAF Test Request Form and the sample.
* C43, melanoma; C80, malignant neoplasm, unspecified; Z85, personal history of malignant neoplasm. The THxID-BRAF kit is a registered trademark of bioMérieux, Inc.
VISIT KnowNowBRAF.com TO LEARN MORE ABOUT THE KNOW NOW BRAF TESTING PROGRAM OR TO CONTACT A NOVARTIS REPRESENTATIVE
KNOW YOUR PATIENT’S BRAF MUTATION STATUS BEFORE YOU MAKE YOUR TREATMENT DECISION
NOVARTIS UNDERSTANDS MELANOMA AND THE IMPORTANCE OF TESTING EVERY PATIENT
BRAF mutation status is an important prognostic factor when choosing a first-line therapy for your patients with stage IIIB/C or stage IV melanoma.1,2 Knowing the BRAF status of each of your patients may help you understand all the treatment options that are available.
References: 1. Houben R, Becker JC, Kappel A, et al. Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinog. 2004;3:6. doi:10.1186/1477-3163-3-6. 2. Barbour AP, Tang YH, Armour N, et al. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy. Eur J Cancer. 2014;50(15):2668-2676.
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAMINTRODUCTION
123
HOW TO USE THE KNOW NOW BRAF TESTING PROGRAM
You will receive your patient’s test results approximately 48 hours after the Quest central lab (San Juan Capistrano, California) receives the following required program components: Completed BRAF Test Request Form Patient’s pathology report Patient’s pathology sample
The cost of the test is covered by the Know Now BRAF Testing Program, regardless of your patient’s results.Once you know your patient's BRAF status, you can understand all the treatment options that are available for your patient with stage III or stage IV melanoma.
Contact the dedicated Enterprise Account Call Center at 1-866-226-8046 for any questions you may have about the Know Now BRAF Testing Program
Send in your patient's pathology report and completed BRAF Test Request Form by fax (1-610-271-3881) or email ([email protected]).
Download and fill out the BRAF Test Request Form (Additional forms can be acquired from your Novartis Representative)
Submit the testing request along with your patient’s pathology report to the Enterprise Account Team
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAMHOW TO USE THE PROGRAM
ABOUT THE PROGRAM:Q: What is the Know Now BRAF Testing Program?A: The Know Now BRAF Testing Program is a collaboration between Novartis and Quest Diagnostics designed to educate you about the
importance of BRAF testing for your patients with stage III or stage IV melanoma.
Q: Which diagnostic tool does Quest use to conduct a BRAF test?A: Quest will use the THxID®-BRAF kit test to perform BRAF V600E/K mutation testing for stage III or stage IV melanoma. The
THxID-BRAF kit is a registered trademark of bioMérieux, Inc.
PATIENT ELIGIBILITY & PAYMENT:Q: Who is eligible for the Know Now BRAF Testing Program?A: Any patient who has stage III or stage IV melanoma.
Q: Are patients who are covered by federal, state, or local government insurance programs able to participate in the program?A: Yes, all patients with stage III or stage IV melanoma are eligible to participate.
KNOW NOW BRAF TESTING PROGRAMKnowNowBRAF.com
Contact a Novartis Representative
FAQs
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAM FAQs/CONTACT US
PATIENT ELIGIBILITY & PAYMENT (continued):
Q: Who will pay for the BRAF test from Quest?A: Novartis will cover the cost for all tests. Neither you nor the patient will receive a bill. Reimbursement must not be sought from any
insurance provider.
Q: Will Novartis cover the cost if the BRAF test is negative?A: Yes, Novartis will cover the cost of the test regardless of BRAF mutation status.
RESOURCES AND CONTACT INFORMATION:Q: Where can you find additional information about the program?A: The Know Now BRAF Testing Program website, KnowNowBRAF.com, offers program details, downloadable BRAF Test Request Forms, and
contact information for local Novartis Representatives.
KNOW NOW BRAF TESTING PROGRAMKnowNowBRAF.com
Contact a Novartis Representative
FAQs
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAM FAQs/CONTACT US
KNOW NOW BRAF TESTING PROGRAMKnowNowBRAF.com
FAQsORDERING THE TEST:Q: How do you participate in the Know Now BRAF Testing Program?A: You will need to complete and send the following items to Quest:
1. BRAF Test Request Form
2. Patient’s pathology report
3. Patient’s pathology sample
Q: What are the requirements for the patient’s pathology sample?A: A minimum of 5 slides at 5-µm thickness and 1 slide for hematoxylin and eosin stain at 4-µm thickness are required. Paraffin-embedded
tissue containing less than 50% tumor cell will undergo microdissection.
Q: Where can you obtain the forms necessary to use the testing program with Quest?A: The forms can be provided by the Novartis Representative or downloaded from the website KnowNowBRAF.com.
Q: Which Quest facility will perform the test?A: The sample testing center for the Know Now BRAF Testing Program is in San Juan Capistrano, California.
Q: How do you order the test on a sample that has already been taken and sent to a Quest lab?A: Quest lab will request the paraffin block or 5 slides via the Quest Block SOP (Standard Operating Procedure). The sample will be sent to the
testing center in San Juan Capistrano, California, for BRAF testing.
Contact a Novartis Representative
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAM FAQs/CONTACT US
Contact a Novartis Representative
KNOW NOW BRAF TESTING PROGRAMKnowNowBRAF.com
Novartis Pharmaceuticals CorporationEast Hanover, New Jersey 07936-1080 © 2019 Novartis 4/19 MLN-1211903
FAQsORDERING THE TEST (continued):
Q: On the BRAF Test Request Form, what is the “Patient ID”?A: The Patient ID is the identification number used by your office to identify the patient. When calling regarding a request form, your office
may refer to this number.
RECEIVING TEST RESULTS:Q: How soon will you receive the test results from Quest?A: You will receive his/her patient’s test results approximately 48 hours after the Quest lab (San Juan Capistrano, California) receives the
following required program components:
1. Completed BRAF Test Request Form
2. Patient’s pathology report
3. Patient’s pathology sample
Quest will not process test requests until all completed forms and associated samples are received.
Q: How will you receive the test results?A: You will receive a secure fax with the test results.
INTRODUCTION FAQs/CONTACT USHOW TO USE THE PROGRAM FAQs/CONTACT US
